Literature DB >> 24634004

Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine.

Min Zheng1, Shi Liu, Jing Li, Dan Qu, Haifeng Zhao, Xingang Guan, Xiuli Hu, Zhigang Xie, Xiabin Jing, Zaicheng Sun.   

Abstract

A theranostic nanomedicine (CD-Oxa) is synthesized by means of the condensation reaction between the amino groups on the surface of fluorescent carbon dots (CDs) and the carboxyl group of the oxaliplatin derivative Oxa(IV)-COOH. CD-Oxa, which integrates the optical properties of CDs and the anticancer function of oxaliplatin, could be used for simultaneous drug delivery and fluorescent tracking.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bioimaging; bionanotechnology; carbon nanoparticles; oxaliplatin; personalized medicine; theranostics

Mesh：

Substances：

Year:  2014        PMID： 24634004     DOI： 10.1002/adma.201306192

Source DB:  PubMed          Journal:  Adv Mater        ISSN： 0935-9648            Impact factor:   30.849


  46 in total

Review 1.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

Review 2.  Nanoparticle-mediated targeted drug delivery for breast cancer treatment.

Authors:  Piumi Y Liyanage; Sajini D Hettiarachchi; Yiqun Zhou; Allal Ouhtit; Elif S Seven; Cagri Y Oztan; Emrah Celik; Roger M Leblanc
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

3.  A signal-on ratiometric fluorometric heparin assay based on the direct interaction between amino-modified carbon dots and DNA.

Authors:  Jianyong Huang; Fenglan Li; Rubin Guo; Yuyuan Chen; Zhenzhen Wang; Chengfei Zhao; Yanjie Zheng; Shaohuang Weng; Xinhua Lin
Journal:  Mikrochim Acta       Date:  2018-04-21       Impact factor: 5.833

Review 4.  Quantum dots in biomedical applications.

Authors:  Angela M Wagner; Jennifer M Knipe; Gorka Orive; Nicholas A Peppas
Journal:  Acta Biomater       Date:  2019-05-11       Impact factor: 8.947

5.  Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release.

Authors:  Jinfeng Zhang; Shengliang Li; Fei-Fei An; Juan Liu; Shubin Jin; Jin-Chao Zhang; Paul C Wang; Xiaohong Zhang; Chun-Sing Lee; Xing-Jie Liang
Journal:  Nanoscale       Date:  2015-07-22       Impact factor: 7.790

6.  Doxorubicin conjugated carbon dots as a drug delivery system for human breast cancer therapy.

Authors:  Tingting Kong; Liying Hao; Yuanyuan Wei; Xiaoxiao Cai; Bofeng Zhu
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

7.  Hydrothermal Synthesis of Nitrogen-Doped Carbon Quantum Dots as Fluorescent Probes for the Detection of Dopamine.

Authors:  Chunxi Zhao; Yang Jiao; Jianhao Hua; Jian Yang; Yaling Yang
Journal:  J Fluoresc       Date:  2017-11-07       Impact factor: 2.217

8.  Biocompatible and blood-brain barrier permeable carbon dots for inhibition of Aβ fibrillation and toxicity, and BACE1 activity.

Authors:  Xu Han; Zhifeng Jing; Wei Wu; Bing Zou; Zhili Peng; Pengyu Ren; Athula Wikramanayake; Zhongmin Lu; Roger M Leblanc
Journal:  Nanoscale       Date:  2017-09-14       Impact factor: 7.790

Review 9.  Citrate-Based Fluorescent Biomaterials.

Authors:  Dingying Shan; Jer-Tsong Hsieh; Xiaochun Bai; Jian Yang
Journal:  Adv Healthc Mater       Date:  2018-07-26       Impact factor: 9.933

Review 10.  Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.

Authors:  Arun Radhakrishnan; Gowthamarajan Kuppusamy; Sivasankaran Ponnusankar; Nikhitha K Shanmukhan
Journal:  Pharmacogenomics J       Date:  2019-12-10       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.